‘Our findings mean that northern Scotland has among the highest rates of Huntington’s disease in the world. Its prevalence is almost three times greater than reported elsewhere in Europe (4.7 per 100,000); North America (4.1-5.2 per 100,000); Japan (0.1 per 100,000); Australia (5.70 per 100,000 people) – and more than five times the estimated worldwide rate of 2.71 per 100,000 people.’
You are here: Home / Archives for Zofia Miedzybrodzka
Zofia Miedzybrodzka
About Zofia Miedzybrodzka
Personal Chair (Clinical) Medical Genetics, University of Aberdeen. (Zofia Miedzybrodzka receives funding from NHS Grampian Huntington disease endowment fund, CHDI, EHDN and the Chief Scientist Office to support Huntington's disease research. NHS Grampian receives funding on behalf of Prof Miedzybrodzka as reimbursement of expenses for the centre taking part in clinical trials in HD from Roche and Prilenia, and from Novartis for consultancy.)